The generalized rash: part I. Differential diagnosis
- PMID:20229971
The generalized rash: part I. Differential diagnosis
Abstract
Physicians often have difficulty diagnosing a generalized rash because many different conditions produce similar rashes, and a single condition can result in different rashes with varied appearances. A rapid and accurate diagnosis is critically important to make treatment decisions, especially when mortality or significant morbidity can occur without prompt intervention. When a specific diagnosis is not immediately apparent, it is important to generate an inclusive differential diagnosis to guide diagnostic strategy and initial treatment. In part I of this two-part article, tables listing common, uncommon, and rare causes of generalized rash are presented to help generate an inclusive differential diagnosis. The tables describe the key clinical features and recommended tests to help accurately diagnose generalized rashes. If the diagnosis remains unclear, the primary care physician must decide whether to observe and treat empirically, perform further diagnostic testing, or refer the patient to a dermatologist. This decision depends on the likelihood of a serious disorder and the patient's response to treatment.
Similar articles
- The generalized rash: part II. Diagnostic approach.Ely JW, Seabury Stone M.Ely JW, et al.Am Fam Physician. 2010 Mar 15;81(6):735-9.Am Fam Physician. 2010.PMID:20229972Review.
- A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.Foy JM, Earls MF.Foy JM, et al.Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953.Pediatrics. 2005.PMID:15629972
- Evaluating the febrile patient with a rash.McKinnon HD Jr, Howard T.McKinnon HD Jr, et al.Am Fam Physician. 2000 Aug 15;62(4):804-16.Am Fam Physician. 2000.PMID:10969859Review.
- Newborn skin: Part I. Common rashes.O'Connor NR, McLaughlin MR, Ham P.O'Connor NR, et al.Am Fam Physician. 2008 Jan 1;77(1):47-52.Am Fam Physician. 2008.PMID:18236822Review.
- Store-and-forward teledermatology versus in-person visits: a comparison in pediatric teledermatology clinic.Heffner VA, Lyon VB, Brousseau DC, Holland KE, Yen K.Heffner VA, et al.J Am Acad Dermatol. 2009 Jun;60(6):956-61. doi: 10.1016/j.jaad.2008.11.026. Epub 2009 Apr 11.J Am Acad Dermatol. 2009.PMID:19362751
Cited by
- The mixed spongiotic and interface reaction pattern: A study of clinical and histopathologic findings.Ernst M, Lundgren M, Evans MD, Miller D, Giubellino A.Ernst M, et al.J Cutan Pathol. 2022 Dec;49(12):1051-1059. doi: 10.1111/cup.14306. Epub 2022 Aug 18.J Cutan Pathol. 2022.PMID:36445270Free PMC article.
- Delayed hypersensitivity reaction to allopurinol: A case report.Mohammad CM, Shahidah CA, Wan Fatimah SWM, Salman A, Mohd Zhafri MR, Rasimah I.Mohammad CM, et al.Malays Fam Physician. 2023 Feb 20;18:11. doi: 10.51866/cr.65. eCollection 2023.Malays Fam Physician. 2023.PMID:36992954Free PMC article.
- Immunomodulatory Plant Natural Products as Therapeutics against Inflammatory Skin Diseases.Kumar NS, Reddy N, Kumar H, Vemireddy S.Kumar NS, et al.Curr Top Med Chem. 2024;24(12):1013-1034. doi: 10.2174/0115680266277952240223120435.Curr Top Med Chem. 2024.PMID:38485678Review.
- Hydrogen(H2) treatment for acute erythymatous skin diseases. A report of 4 patients with safety data and a non-controlled feasibility study with H2 concentration measurement on two volunteers.Ono H, Nishijima Y, Adachi N, Sakamoto M, Kudo Y, Nakazawa J, Kaneko K, Nakao A.Ono H, et al.Med Gas Res. 2012 May 20;2(1):14. doi: 10.1186/2045-9912-2-14.Med Gas Res. 2012.PMID:22607973Free PMC article.
- COVID-19 and cutaneous manifestations: A review of the published literature.Martora F, Villani A, Fabbrocini G, Battista T.Martora F, et al.J Cosmet Dermatol. 2023 Jan;22(1):4-10. doi: 10.1111/jocd.15477. Epub 2022 Nov 7.J Cosmet Dermatol. 2023.PMID:36342945Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical